PHARMACOLOGY NURSING
Final Exam Complete Study Guide
150 Drug Therapy Questions with Correct Answers and Rationales
Academic Year: 2026
Credential: BSN / ADN Pre-Licensure
Course: Pharmacology Nursing (NUR 200 / PHARM 300)
Question Count: 150 Questions
Format: Multiple-Choice
Alignment: NCLEX-RN, ISMP, AHA, ADA, AHA
Anticoagulation Guidelines
Aligned with Lehne's Pharmacology, Adams' Pharmacology for Nurses, ISMP High-Alert Guidelines, NCLEX-RN Test Plan
Pharmacology Nursing Final Exam Study Guide | Page 1
,Table of Contents
Table of Contents.......................................................................................................................................... 2
Introduction .................................................................................................................................................. 3
Section I: Pharmacokinetics, Pharmacodynamics & Cardiovascular Pharmacology ........................... 3
Section II: Respiratory, Endocrine & Antibiotic Pharmacology ........................................................... 15
Section III: CNS, Pain, Psychiatric, GI, Oncology & Legal/Ethical ...................................................... 27
Quick-Reference Answer Key ................................................................................................................... 40
References ................................................................................................................................................... 41
Table of Contents.......................................................................................................................................... 2
Introduction .................................................................................................................................................. 3
Section I: Pharmacokinetics, Pharmacodynamics & Cardiovascular Pharmacology ........................... 3
Section II: Respiratory, Endocrine & Antibiotic Pharmacology ........................................................... 15
Section III: CNS, Pain, Psychiatric, GI, Oncology & Legal/Ethical ...................................................... 27
Quick-Reference Answer Key ................................................................................................................... 40
References ................................................................................................................................................... 41
Pharmacology Nursing Final Exam Study Guide | Page 2
,Introduction
This Pharmacology Nursing Final Exam Study Guide provides 150 practice questions aligned with
comprehensive pharmacology course content for pre-licensure BSN/ADN programs. Questions are organized
into three major sections covering pharmacokinetics/pharmacodynamics, cardiovascular/respiratory/endocrine
pharmacology, antibiotics and anti-infectives, pain management, CNS/psychiatric medications,
GI/hepatobiliary drugs, oncology pharmacology, special populations, and legal/ethical standards. Each question
includes four answer options with the correct answer in bold cyan and a detailed rationale referencing current
clinical guidelines and nursing standards.
Content Domain Questions Approx. Weight
PK/PD & Cardiovascular Pharmacology 1–50 33%
Respiratory, Endocrine & Antibiotics 51–100 33%
CNS/Pain, Psych, GI, Oncology, Legal 101–150 34%
Section I: Pharmacokinetics, Pharmacodynamics &
Cardiovascular Pharmacology
This section covers ADME processes, half-life, therapeutic index, first-pass effect, protein binding, medication
administration principles (Six Rights + Two), high-alert medication protocols, antihypertensives (ACE-I,
ARBs, beta-blockers, CCBs, diuretics), antianginals, anticoagulants (warfarin, heparin, DOACs), antiplatelets,
statins, and heart failure pharmacology.
1. A nurse is reviewing the medication profile of a client receiving oral morphine. The nurse understands that
the first-pass effect refers to which process?
A) Inactivation of a portion of the drug by the liver B) Enhanced absorption of the drug through the
before reaching systemic circulation intestinal mucosa
C) Increased renal excretion of the drug during the D) Rapid distribution of the drug to highly perfused
initial dose organs
Correct Answer: A
Rationale: The first-pass effect occurs when an orally administered drug is partially metabolized by the liver before entering the
systemic circulation, reducing bioavailability. Morphine has significant first-pass metabolism, which is why IV administration
produces a greater effect at a lower dose. The nurse should recognize that switching a client from oral to IV morphine requires a
dosage reduction to prevent toxicity.
2. A client asks the nurse why their medication must be taken sublingually rather than swallowed. Which
response by the nurse is most appropriate?
A) Sublingual administration bypasses the first-pass B) The drug is too irritating to the gastric mucosa to be
effect, allowing faster onset. swallowed.
C) Sublingual drugs require gastric acid for activation. D) Sublingual absorption is slower, providing a
prolonged effect.
Correct Answer: A
Rationale: Sublingual administration allows the drug to be absorbed directly into the systemic circulation through the highly
vascular oral mucosa, bypassing the hepatic first-pass effect. This results in a faster onset of action compared to the oral route.
Nitroglycerin is a classic example prescribed sublingually for acute angina episodes because rapid vasodilation is needed.
3. A patient with chronic pain is prescribed a drug with a half-life of 6 hours. Approximately how long will it
take for the drug to reach steady-state concentration?
Pharmacology Nursing Final Exam Study Guide | Page 3
, A) 6 hours B) 12 hours
C) 24 to 30 hours D) 48 hours
Correct Answer: C
Rationale: Steady state is achieved after approximately 4 to 5 half-lives of a drug. For a drug with a 6-hour half-life, steady state
is reached in 24 to 30 hours (4-5 x 6). Understanding half-life is essential for the nurse to anticipate when therapeutic effects and
potential adverse effects will stabilize, and to educate patients about the time course of their medication.
4. A nurse is administering warfarin to a patient who is also taking phenytoin, a highly protein-bound drug. The
nurse should anticipate which potential interaction?
A) Increased free (unbound) warfarin levels, B) Decreased free phenytoin levels, resulting in seizure
increasing the risk of bleeding breakthrough
C) Formation of a toxic complex that must be D) Decreased effectiveness of both drugs due to
eliminated by hemodialysis accelerated renal clearance
Correct Answer: A
Rationale: When two highly protein-bound drugs are administered concurrently, they compete for binding sites on plasma
proteins such as albumin. Displacement of warfarin from protein-binding sites increases the amount of free (active) drug in
circulation, elevating bleeding risk. The nurse should monitor INR closely and assess for signs of bleeding when adding or
removing highly protein-bound medications.
5. The nurse is caring for a patient receiving digoxin. The provider notes that digoxin has a narrow therapeutic
index. What does this mean for the nurse's plan of care?
A) The drug has a large margin of safety between B) The drug is effective only at very high doses.
therapeutic and toxic doses.
C) The difference between a therapeutic dose and a D) The drug is contraindicated in patients with any
toxic dose is very small, requiring close monitoring. level of renal impairment.
Correct Answer: C
Rationale: A narrow therapeutic index means the range between the effective dose and the toxic dose is small, leaving little room
for error. Digoxin and lithium are classic examples. The nurse must monitor serum drug levels, assess for signs of toxicity closely,
and report any changes in the patient's condition such as nausea, visual changes, or arrhythmias promptly.
6. A nursing student is reviewing agonist and antagonist medications. Which statement about these drug classes
is correct?
A) An agonist binds to a receptor and blocks the natural B) An antagonist binds to a receptor and produces a
substance from acting. biological response.
C) An agonist binds to a receptor and mimics the D) An antagonist increases the production of the natural
action of the natural substance. ligand at the receptor site.
Correct Answer: C
Rationale: An agonist binds to a receptor and activates it, mimicking the effect of the endogenous substance (e.g., albuterol at
beta-2 receptors). An antagonist binds to the receptor but does not activate it, instead blocking the action of the natural agonist
(e.g., propranolol at beta receptors). Understanding this distinction helps the nurse predict the therapeutic and adverse effects of
medications.
7. Two drugs, Drug A and Drug B, are being compared in a clinical trial. Drug A produces the same maximum
effect as Drug B but at a lower dose. Which statement is accurate?
A) Drug A has greater potency than Drug B. B) Drug B is a partial agonist compared to Drug A.
C) Drug A has a wider therapeutic index than Drug B. D) Drug A has greater efficacy than Drug B.
Correct Answer: A
Rationale: Potency refers to the amount of drug needed to produce a given effect; a more potent drug requires a lower dose to
achieve the same effect. Efficacy refers to the maximum effect a drug can produce regardless of dose. Since both drugs achieve
the same maximum effect but Drug A requires less drug, Drug A is more potent. The nurse should understand this distinction
when comparing medications within the same class.
Pharmacology Nursing Final Exam Study Guide | Page 4
Final Exam Complete Study Guide
150 Drug Therapy Questions with Correct Answers and Rationales
Academic Year: 2026
Credential: BSN / ADN Pre-Licensure
Course: Pharmacology Nursing (NUR 200 / PHARM 300)
Question Count: 150 Questions
Format: Multiple-Choice
Alignment: NCLEX-RN, ISMP, AHA, ADA, AHA
Anticoagulation Guidelines
Aligned with Lehne's Pharmacology, Adams' Pharmacology for Nurses, ISMP High-Alert Guidelines, NCLEX-RN Test Plan
Pharmacology Nursing Final Exam Study Guide | Page 1
,Table of Contents
Table of Contents.......................................................................................................................................... 2
Introduction .................................................................................................................................................. 3
Section I: Pharmacokinetics, Pharmacodynamics & Cardiovascular Pharmacology ........................... 3
Section II: Respiratory, Endocrine & Antibiotic Pharmacology ........................................................... 15
Section III: CNS, Pain, Psychiatric, GI, Oncology & Legal/Ethical ...................................................... 27
Quick-Reference Answer Key ................................................................................................................... 40
References ................................................................................................................................................... 41
Table of Contents.......................................................................................................................................... 2
Introduction .................................................................................................................................................. 3
Section I: Pharmacokinetics, Pharmacodynamics & Cardiovascular Pharmacology ........................... 3
Section II: Respiratory, Endocrine & Antibiotic Pharmacology ........................................................... 15
Section III: CNS, Pain, Psychiatric, GI, Oncology & Legal/Ethical ...................................................... 27
Quick-Reference Answer Key ................................................................................................................... 40
References ................................................................................................................................................... 41
Pharmacology Nursing Final Exam Study Guide | Page 2
,Introduction
This Pharmacology Nursing Final Exam Study Guide provides 150 practice questions aligned with
comprehensive pharmacology course content for pre-licensure BSN/ADN programs. Questions are organized
into three major sections covering pharmacokinetics/pharmacodynamics, cardiovascular/respiratory/endocrine
pharmacology, antibiotics and anti-infectives, pain management, CNS/psychiatric medications,
GI/hepatobiliary drugs, oncology pharmacology, special populations, and legal/ethical standards. Each question
includes four answer options with the correct answer in bold cyan and a detailed rationale referencing current
clinical guidelines and nursing standards.
Content Domain Questions Approx. Weight
PK/PD & Cardiovascular Pharmacology 1–50 33%
Respiratory, Endocrine & Antibiotics 51–100 33%
CNS/Pain, Psych, GI, Oncology, Legal 101–150 34%
Section I: Pharmacokinetics, Pharmacodynamics &
Cardiovascular Pharmacology
This section covers ADME processes, half-life, therapeutic index, first-pass effect, protein binding, medication
administration principles (Six Rights + Two), high-alert medication protocols, antihypertensives (ACE-I,
ARBs, beta-blockers, CCBs, diuretics), antianginals, anticoagulants (warfarin, heparin, DOACs), antiplatelets,
statins, and heart failure pharmacology.
1. A nurse is reviewing the medication profile of a client receiving oral morphine. The nurse understands that
the first-pass effect refers to which process?
A) Inactivation of a portion of the drug by the liver B) Enhanced absorption of the drug through the
before reaching systemic circulation intestinal mucosa
C) Increased renal excretion of the drug during the D) Rapid distribution of the drug to highly perfused
initial dose organs
Correct Answer: A
Rationale: The first-pass effect occurs when an orally administered drug is partially metabolized by the liver before entering the
systemic circulation, reducing bioavailability. Morphine has significant first-pass metabolism, which is why IV administration
produces a greater effect at a lower dose. The nurse should recognize that switching a client from oral to IV morphine requires a
dosage reduction to prevent toxicity.
2. A client asks the nurse why their medication must be taken sublingually rather than swallowed. Which
response by the nurse is most appropriate?
A) Sublingual administration bypasses the first-pass B) The drug is too irritating to the gastric mucosa to be
effect, allowing faster onset. swallowed.
C) Sublingual drugs require gastric acid for activation. D) Sublingual absorption is slower, providing a
prolonged effect.
Correct Answer: A
Rationale: Sublingual administration allows the drug to be absorbed directly into the systemic circulation through the highly
vascular oral mucosa, bypassing the hepatic first-pass effect. This results in a faster onset of action compared to the oral route.
Nitroglycerin is a classic example prescribed sublingually for acute angina episodes because rapid vasodilation is needed.
3. A patient with chronic pain is prescribed a drug with a half-life of 6 hours. Approximately how long will it
take for the drug to reach steady-state concentration?
Pharmacology Nursing Final Exam Study Guide | Page 3
, A) 6 hours B) 12 hours
C) 24 to 30 hours D) 48 hours
Correct Answer: C
Rationale: Steady state is achieved after approximately 4 to 5 half-lives of a drug. For a drug with a 6-hour half-life, steady state
is reached in 24 to 30 hours (4-5 x 6). Understanding half-life is essential for the nurse to anticipate when therapeutic effects and
potential adverse effects will stabilize, and to educate patients about the time course of their medication.
4. A nurse is administering warfarin to a patient who is also taking phenytoin, a highly protein-bound drug. The
nurse should anticipate which potential interaction?
A) Increased free (unbound) warfarin levels, B) Decreased free phenytoin levels, resulting in seizure
increasing the risk of bleeding breakthrough
C) Formation of a toxic complex that must be D) Decreased effectiveness of both drugs due to
eliminated by hemodialysis accelerated renal clearance
Correct Answer: A
Rationale: When two highly protein-bound drugs are administered concurrently, they compete for binding sites on plasma
proteins such as albumin. Displacement of warfarin from protein-binding sites increases the amount of free (active) drug in
circulation, elevating bleeding risk. The nurse should monitor INR closely and assess for signs of bleeding when adding or
removing highly protein-bound medications.
5. The nurse is caring for a patient receiving digoxin. The provider notes that digoxin has a narrow therapeutic
index. What does this mean for the nurse's plan of care?
A) The drug has a large margin of safety between B) The drug is effective only at very high doses.
therapeutic and toxic doses.
C) The difference between a therapeutic dose and a D) The drug is contraindicated in patients with any
toxic dose is very small, requiring close monitoring. level of renal impairment.
Correct Answer: C
Rationale: A narrow therapeutic index means the range between the effective dose and the toxic dose is small, leaving little room
for error. Digoxin and lithium are classic examples. The nurse must monitor serum drug levels, assess for signs of toxicity closely,
and report any changes in the patient's condition such as nausea, visual changes, or arrhythmias promptly.
6. A nursing student is reviewing agonist and antagonist medications. Which statement about these drug classes
is correct?
A) An agonist binds to a receptor and blocks the natural B) An antagonist binds to a receptor and produces a
substance from acting. biological response.
C) An agonist binds to a receptor and mimics the D) An antagonist increases the production of the natural
action of the natural substance. ligand at the receptor site.
Correct Answer: C
Rationale: An agonist binds to a receptor and activates it, mimicking the effect of the endogenous substance (e.g., albuterol at
beta-2 receptors). An antagonist binds to the receptor but does not activate it, instead blocking the action of the natural agonist
(e.g., propranolol at beta receptors). Understanding this distinction helps the nurse predict the therapeutic and adverse effects of
medications.
7. Two drugs, Drug A and Drug B, are being compared in a clinical trial. Drug A produces the same maximum
effect as Drug B but at a lower dose. Which statement is accurate?
A) Drug A has greater potency than Drug B. B) Drug B is a partial agonist compared to Drug A.
C) Drug A has a wider therapeutic index than Drug B. D) Drug A has greater efficacy than Drug B.
Correct Answer: A
Rationale: Potency refers to the amount of drug needed to produce a given effect; a more potent drug requires a lower dose to
achieve the same effect. Efficacy refers to the maximum effect a drug can produce regardless of dose. Since both drugs achieve
the same maximum effect but Drug A requires less drug, Drug A is more potent. The nurse should understand this distinction
when comparing medications within the same class.
Pharmacology Nursing Final Exam Study Guide | Page 4
